Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Anectine 50mg/ml Solution for Injection or Infusion – PA1691/033/001
- Canesten HC Cream 1.0% w/w – PA1410/040/001
- Estradot 37.5mcg/day Transdermal Patch – PA0896/010/001
- Flucol 200mg Capsule – PA0711/057/004
- Folinic Acid 10mg/ml Solution for Injection (50mg/5ml presentation only) – PA0822/198/003
- Gabapentin Rosemount 50mg/ml Oral Solution – PA0312/025/001
- Havrix Monodose Vaccine (Adult) Suspension for Injection in Prefilled Syringe – PA1077/026/002
- Trandate 5mg/ml Solution for Injection – PA1638/006/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Aciclovir 25mg/ml Concentrate for Solution for Infusion (500mg/20ml presentation) – PA0822/215/001
- Bricanyl Turbohaler 500mcg per metered dose, Inhalation Powder – PA1019/007/002
- Nozinan 25mg/ml Solution for Injection/Infusion – PA0540/115/001
- One-Alpha 0.25mcg Soft Capsule – PA0046/024/002
- Piperacillin Tazobactam 4g/0.5g Powder for Solution for Infusion – PA0577/204/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.